Prognosis
"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Descriptor ID |
D011379
|
MeSH Number(s) |
E01.789
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 0 | 13 | 13 | 1981 | 0 | 11 | 11 | 1982 | 0 | 10 | 10 | 1983 | 0 | 14 | 14 | 1984 | 0 | 11 | 11 | 1985 | 0 | 14 | 14 | 1986 | 0 | 11 | 11 | 1987 | 0 | 8 | 8 | 1988 | 0 | 18 | 18 | 1989 | 0 | 18 | 18 | 1990 | 0 | 14 | 14 | 1991 | 0 | 19 | 19 | 1992 | 0 | 15 | 15 | 1993 | 0 | 14 | 14 | 1994 | 0 | 22 | 22 | 1995 | 0 | 23 | 23 | 1996 | 0 | 29 | 29 | 1997 | 0 | 22 | 22 | 1998 | 0 | 31 | 31 | 1999 | 0 | 36 | 36 | 2000 | 0 | 55 | 55 | 2001 | 0 | 37 | 37 | 2002 | 0 | 29 | 29 | 2003 | 1 | 53 | 54 | 2004 | 0 | 58 | 58 | 2005 | 0 | 67 | 67 | 2006 | 0 | 48 | 48 | 2007 | 0 | 73 | 73 | 2008 | 1 | 88 | 89 | 2009 | 1 | 91 | 92 | 2010 | 0 | 91 | 91 | 2011 | 0 | 126 | 126 | 2012 | 0 | 119 | 119 | 2013 | 0 | 135 | 135 | 2014 | 1 | 121 | 122 | 2015 | 1 | 133 | 134 | 2016 | 1 | 126 | 127 | 2017 | 2 | 132 | 134 | 2018 | 3 | 137 | 140 | 2019 | 1 | 152 | 153 | 2020 | 1 | 131 | 132 | 2021 | 1 | 91 | 92 | 2022 | 0 | 40 | 40 | 2023 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Pugashetti JV, Adegunsoye A, Wu Z, Lee CT, Srikrishnan A, Ghodrati S, Vo V, Renzoni EA, Wells AU, Garcia CK, Chua F, Newton CA, Molyneaux PL, Oldham JM. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 01 01; 207(1):69-76.
-
Cantu MD, Kanagal-Shamanna R, Wang SA, Kadia T, Bueso-Ramos CE, Patel SS, Geyer JT, Tam W, Madanat Y, Li P, George TI, Nichols MM, Rogers HJ, Liu YC, Aggarwal N, Kurzer JH, Maracaja DLV, Hsi ED, Zaiem F, Babu D, Foucar K, Laczko D, Bagg A, Orazi A, Arber DA, Hasserjian RP, Weinberg OK. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO Precis Oncol. 2023 Jan; 7:e2200400.
-
Wang X, Liu Y, Lu Y, Chen S, Xing Y, Yang H, Wang X, Zhang Y, Pan T, Li J, Wang M, Zhang N, Liang M, Zhou F. Clinical impact of Fn-induced high expression of KIR2DL1 in CD8 T lymphocytes in oesophageal squamous cell carcinoma. Ann Med. 2022 Dec; 54(1):51-62.
-
Tibrewala A, Wehbe RM, Wu T, Harap R, Ghafourian K, Wilcox JE, Okwuosa IS, Vorovich EE, Ahmad FS, Yancy C, Pawale A, Anderson AS, Pham DT, Rich JD. Hyponatremia Is a Powerful Predictor of Poor Prognosis in Left Ventricular Assist Device Patients. ASAIO J. 2022 12 01; 68(12):1475-1482.
-
Coca-Pelaz A, Rodrigo JP, Lopez F, Shah JP, Silver CE, Al Ghuzlan A, Menke-van der Houven van Oordt CW, Smallridge RC, Shaha AR, Angelos P, Mendenhall WM, Piazza C, Olsen KD, Corry J, Tufano RP, Sanabria A, Nuyts S, Nathan CA, Vander Poorten V, Dias FL, Suarez C, Saba NF, de Graaf P, Williams MD, Rinaldo A, Ferlito A. Evaluating new treatments for anaplastic thyroid cancer. Expert Rev Anticancer Ther. 2022 11; 22(11):1239-1247.
-
Lazaroff J, Bolotin D. Targeted Therapy and Immunotherapy in Melanoma. Dermatol Clin. 2023 Jan; 41(1):65-77.
-
Ramia de Cap M, Wu LP, Pihan GA, Narayanan D, Morgan EA, Pinkus GS, Cin PD, Hurwitz SN, Bagg A, Patel SS, Tam W, Ouseph MM, Gagan J, Madanat YF, Siddon A, Raess PW, Rogers HJ, Bueso-Ramos CE, Kanagal-Shamanna R, Kurzer JH, Arber DA, Hasserjian RP, Weinberg OK. NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leuk Res. 2022 12; 123:106965.
-
D?hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, R?llig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, L?wenberg B. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022 09 22; 140(12):1345-1377.
-
Xu B, Viswanathan K, Umrau K, Al-Ameri TAD, Dogan S, Magliocca K, Ghossein RA, Cipriani NA, Katabi N. Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors. Histopathology. 2022 Nov; 81(5):670-679.
-
Jahn N, Jahn E, Saadati M, Bullinger L, Larson RA, Ottone T, Amadori S, Prior TW, Brandwein JM, Appelbaum FR, Medeiros BC, Tallman MS, Ehninger G, Heuser M, Ganser A, Pallaud C, Gathmann I, Krzykalla J, Benner A, Bloomfield CD, Thiede C, Stone RM, D?hner H, D?hner K. Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. Leukemia. 2022 09; 36(9):2218-2227.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|